A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in their care, while also making a meaningful impact on the communities we serve. Our diverse, durable product portfolio is sold in more than 90 countries and serves animals across many species, primarily: dogs and cats (collectively, pet health) and cattle, poultry, swine and sheep (collectively, farm animal). Our purpose – making life better for animals makes life better – inspires us to Go Beyond for animals, our customers, our people and society.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.7B | 4.7B | 4.4B | 4.4B | 4.4B | 4.8B |
| Net Income | -232M | -232M | 338M | -1.2B | -78M | -483M |
| EPS | $-0.47 | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 |
| Free Cash Flow | 284M | 284M | 394M | 131M | 281M | 324M |
| ROIC | -0.1% | -0.2% | 3.0% | -0.6% | -0.6% | -3.5% |
| Gross Margin | 55.0% | 55.0% | 54.9% | 56.3% | 56.6% | 55.2% |
| Debt/Equity | 0.63 | 0.63 | 0.73 | 0.95 | 0.82 | 0.86 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -19M | -19M | -18M | -75M | -32M | -335M |
| Operating Margin | -0.4% | -0.4% | -0.4% | -1.7% | -0.7% | -7.0% |
| ROE | -3.5% | -3.7% | 5.5% | -18.2% | -1.1% | -6.1% |
| Shares Outstanding | 494M | 494M | 497M | 492M | 488M | 488M |
Elanco Animal Health Inc passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 41.8x vs a median of 33.4x. The company's 5-year average gross margin is 55.6%. At current prices, the estimated annualized return to fair value is +3.8%.
Elanco Animal Health Inc (ELAN) has a 5-year average return on invested capital (ROIC) of -0.4%. This is below average and may indicate limited pricing power.
Elanco Animal Health Inc (ELAN) has a market capitalization of $11.8B. It is classified as a large-cap stock.
Elanco Animal Health Inc (ELAN) does not currently pay a regular dividend.
Elanco Animal Health Inc (ELAN) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Elanco Animal Health Inc (ELAN) reported annual revenue of $4.7 billion in its most recent fiscal year, based on SEC EDGAR filings.
Elanco Animal Health Inc (ELAN) has a net profit margin of -4.9%. The company is currently unprofitable.
Elanco Animal Health Inc (ELAN) generated $284 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Elanco Animal Health Inc (ELAN) has a debt-to-equity ratio of 0.63. This indicates moderate leverage.
Elanco Animal Health Inc (ELAN) reported earnings per share (EPS) of $-0.47 in its most recent fiscal year.
Elanco Animal Health Inc (ELAN) has a return on equity (ROE) of -3.7%. A negative ROE may indicate losses or negative equity.
Elanco Animal Health Inc (ELAN) has a 5-year average gross margin of 55.6%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 10 years of financial data for Elanco Animal Health Inc (ELAN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Elanco Animal Health Inc (ELAN) has a book value per share of $13.26, based on its most recent annual SEC filing.